Micro-RNAs (miRNAs) are short (average 22 nucleotides) noncoding regulatory RNAs that inhibit gene expression by targeting complementary 3 0 -untranslated regions of proteinencoding mRNAs for translational repression or degradation. miRNAs play key roles in both the function and differentiation of many cell types. Drosha and Dicer, two RNAase III enzymes, function in a stepwise manner to generate a mature miRNA. Previous studies have shown that podocyte-specific deletion of Dicer during development results in proteinuric renal disease and collapsing glomerulopathy (CG); however, Dicer has functions other than the generation of miRNAs. Here we found that the podocyte-specific deletion of Drosha results in a similar phenotype to Dicer mutants, confirming that the Dicer mutant phenotype is due to the loss of miRNAs. Moreover, the inducible deletion of Drosha in 2-to 3-month-old mice (Tet-On system) resulted in CG. Thus, continuous generation of miRNAs are required for the normal function of mature podocytes and their loss leads to CG. Identifying these miRNAs may provide new insight into disease pathogenesis and novel therapeutic targets in various podocytopathies.
Micro-RNAs (miRNAs) are short (average 22 nucleotides) noncoding regulatory RNAs that inhibit gene expression by targeting complementary 3
0 -untranslated regions of proteinencoding mRNAs for translational repression or degradation. miRNAs play key roles in both the function and differentiation of many cell types. Drosha and Dicer, two RNAase III enzymes, function in a stepwise manner to generate a mature miRNA. Previous studies have shown that podocyte-specific deletion of Dicer during development results in proteinuric renal disease and collapsing glomerulopathy (CG); however, Dicer has functions other than the generation of miRNAs. Here we found that the podocyte-specific deletion of Drosha results in a similar phenotype to Dicer mutants, confirming that the Dicer mutant phenotype is due to the loss of miRNAs. Moreover, the inducible deletion of Drosha in 2-to 3-month-old mice (Tet-On system) resulted in CG. Thus, continuous generation of miRNAs are required for the normal function of mature podocytes and their loss leads to CG. Identifying these miRNAs may provide new insight into disease pathogenesis and novel therapeutic targets in various podocytopathies. Micro-RNAs (miRNAs) are short (B22 nucleotides) noncoding regulatory RNAs in plants and animals that inhibit gene expression by targeting protein-encoding mRNAs for translational repression or degradation. 1, 2 MiRNAs bind to complementary sites within the 3 0 -untranslated regions of their target mRNAs. 3, 4 The generation of miRNAs starts from transcription of large RNA precursors, termed pri-miRNAs, from the genome by RNA polymerase II or III. Pri-miRNAs are then processed in the nucleus into shorter sequences of B70 nucleotides, termed pre-miRNAs, by the RNase III enzyme Drosha and the protein Pasha complex. [5] [6] [7] PremiRNAs have imperfect stem-loop structure and are transported into the cytoplasm where the RNase III enzyme, Dicer, and its double-stranded RNA binding partner, the human immunodeficiency virus-1 transactivating response RNA-binding protein, excise double-stranded miRNAs of B22 nucleotides. 8, 9 The miRNA joins the miRISC (miRNAassociated multiprotein RNA-induced silencing complex). 10 The mature miRNA strand is preferentially retained in the miRISC and guides it to the target sequence.
At present, over 1000 miRNAs have been identified in humans/mammals. Current estimates predict that B60% of all human genes are regulated by miRNAs, 11 with a single miRNA capable of binding and regulating 4200 target sequences. A large number of papers have now described the functional roles for miRNAs in a number of biological processes including cell fate and differentiation, development, cell proliferation, and apoptosis. [12] [13] [14] It is also evident that miRNAs play critical roles in maintaining normal health and tissue homeostasis, and changes in miRNA expression are highly relevant to disease processes.
Recently, a number of studies have begun to address the role of miRNAs in kidney disease. 15 These studies have demonstrated that a number of miRNAs are expressed in the kidney, and changes in miRNA expression may contribute to disease. 16, 17 Targeted deletion of Dicer in proximal tubule cells has been shown to protect mice from ischemic reperfusion injury. 18 In diabetic nephropathy, transforming growth factor-b upregulation of miR-216a and miR-217 in mesangial cells may promote their survival and hypertrophy, whereas upregulation of miR-377 by high glucose may contribute to mesangial cell production of fibronectin, 19 and downregulation of miR192 in proximal tubule cells may contribute to interstitial fibrosis. 19, 20 Changes in miRNA expression patterns may also contribute to hepatic and renal cyst formation in autosomal dominant polycystic kidney disease, 21, 22 and may serve as biomarkers for kidney transplant rejection. 23 In addition to the above studies, three reports have recently shown that miRNAs may also play critical roles in podocyte homeostasis. [24] [25] [26] These studies demonstrated that podocyte-specific deletion of Dicer led to podocyte dysregulation, resulting in proteinuric renal disease and collapsing glomerulopathy (CG) with glomerular and tubulointerstitial fibrosis and renal failure at B6-8 weeks of age. However, in addition to playing a critical role in miRNA biogenesis, Dicer also has functions that are independent of miRNA biogenesis. For example, Dicer is also critical for generating small inhibitory RNAs derived from endogenous or exogenous double-stranded RNA transcripts. 27, 28 Thus, although decreased expression of miRNAs in podocytes lacking Dicer has been implicated in the development of the CG phenotype, it is not known whether this phenotype is due solely to the loss of miRNAs or whether miRNA-independent functions of Dicer contribute to the phenotype. Moreover, as Dicer is deleted in developing kidneys in these studies, it still remains to be determined whether the inducible deletion of dicer in a fully developed kidney also results in a similar phenotype.
To address whether the phenotype in podocyte-specific Dicer knockouts (KOs) is due solely to miRNA-dependent regulation of normal podocyte function, or whether other functions of Dicer contribute to the phenotype observed, we generated mice in which Drosha was specifically deleted in podocytes. We found that specifically inactivating Drosha in podocytes led to CG that was comparable with the podocytespecific Dicer KOs previously described. In addition, we found that inducibly deleting Drosha in podocytes at 2 months of age also led to a CG. Thus, these findings reinforce the critical role for miRNAs in normal podocyte biology and suggest that identifying changes in miRNA expression in various podocyte diseases may provide novel therapeutic targets to treat disease.
RESULTS

Podocyte-specific deletion of Drosha results in CG that is comparable with Dicer KOs
Drosha fl/fl mice have been previously described, 29 in which exon 9 is flanked by loxP sites. Deletion of exon 9 disrupts both the full-length Drosha and two alternately spliced forms and results in a frameshift and the appearance of multiple stop codons. Podocyte-specific Drosha KO mice were generated by breeding Drosha fl/fl to NPHS2-Cre; Drosha fl/ þ (NPHS2-Cre mice were provided by L Holzman, University of Michigan). Dicer fl/fl mice were provided by M McManus (University of California, San Francisco, CA) and have been previously described. 30 Podocyte-specific Dicer KOs were generated by crossing Dicer fl/fl to NPHS2-Cre; Dicer fl/ þ . NPHS2-Cre; Drosha fl/fl mice were born at the expected Mendelian frequency. However, NPHS2-Cre; Drosha fl/fl mice developed proteinuria at about B2 to 3 weeks of age that progressed overtime with renal failure and death occurring between 4 and 8 weeks of age ( Figure 1 and data not shown). NPHS2-Cre; Drosha fl/ þ mice containing a heterozygous deletion of Drosha in podocytes were phenotypically normal and did not develop proteinuria or histological evidence of kidney disease up until 12 months of age.
Histological examination of NPHS2-Cre; Drosha fl/fl mice until postnatal day 14 revealed normal glomeruli with no apparent abnormality in glomerular development by either light or electron microscopy (data not shown). However, significant glomerular pathology became apparent after postnatal day 14 that progressed over time. Tables 1  and 2 ). Pseudocrescent formation was found in B45% of glomeruli and segmental or global sclerosis was seen in 28% of the total number of glomeruli, indicating progression of the disease. Simultaneously, the remaining parenchyma was also remarkable for extensive microcyst formation (3 þ ) ( Figure 2a and Tables 1 and 2 ). On ultrastructural analysis, collapsing features were more severe and complete occlusion of the glomerular capillary lumina by severe collapse of the glomerular basement membranes could be appreciated, together with extensive podocyte injury with the loss of primary and secondary foot processes (Figure 2b , advanced). These changes were proportional to the extent and duration of proteinuria. Similar pathology was found in kidneys from NPHS2-Cre; Dicer fl/fl mice (Tables 1 and 2 and Figure 2a and b), although kidneys from NPHS2-Cre; Drosha fl/fl mice exhibited more severe disease at younger age (data not shown).
Deletion of Drosha in podocytes leads to podocyte dedifferentiation and loss of the podocyte-specific markers synaptopodin, Wilms' tumor-1 (WT-1), podocin, and nephrin CG is associated with podocyte dedifferentiation and loss of podocyte-specific markers. Podocytes from NPHS2-Cre; Drosha fl/fl mice exhibited loss of synaptopodin and WT-1, which was first noted at the onset of proteinuria and progressed over time as the kidney disease progressed ( Figure 3 and Table 3 ). Similar findings were found in kidneys from NPHS2-Cre; Dicer fl/fl mice ( Figure 3 and Table 3 ), with the exception that WT-1 expression was lost at an earlier age in NPHS2-Cre; Drosha fl/fl mice, which is consistent with kidneys from NPHS2-Cre; Drosha fl/fl mice exhibiting a more severe phenotype at an earlier age (data not shown).
Podocin and nephrin expression were examined by immunofluorescent staining in NPHS2-Cre; Drosha fl/fl mice of different ages to further characterize the temporal course of podocyte injury. The glomeruli of NPHS2-Cre; Drosha fl/fl mice with minimal changes of CG (age 2 weeks) showed near-normal levels of nephrin and podocin expression when compared with wild-type animals ( Figure 4a and b), indicating that podocyte development is normal in NPHS2-Cre; Drosha fl/fl mice. However, at 5-6 weeks of age when NPHS2-Cre; Drosha fl/fl mice have severe CG, levels of both nephrin and podocin were significantly reduced in glomeruli of NPHS2-Cre; Drosha fl/fl mice. Nephrin and podocin also displayed a disorganized and granular pattern of distribution in NPHS2-Cre; Drosha fl/fl mice that could also be appreciated in glomeruli with early podocyte injury (Figure 4a and b).
Deletion of Drosha in podocytes leads to increased podocyte proliferation and apoptosis and upregulation of desmin and smooth muscle actin (SMA) Tissue injury in a number of different cell types is frequently associated with increased expression of intermediate filament proteins. 31 In podocytes, the intermediate filament protein desmin is upregulated in a number of experimental models of podocyte injury. [32] [33] [34] Desmin is also upregulated in glomeruli in NPHS2-Cre; Drosha fl/fl mice, which is consistent with significant podocyte damage in these mice. Desmin-positive cells were primarily localized to proliferating cells (Ki-67 positive) in the urinary space, which were likely podocytes because they also stained for the podocyte-specific marker nestin 35 ( Figure 5 and Table 3 ). Quantification of podocyte proliferation in NPHS2-Cre; Drosha fl/fl mice demonstrated an increase in the proliferative index (PI) in epithelial cells in the urinary space (Table 4, Global collapse: global wrinkling and folding of the glomerular basement membranes with hypertrophy and hyperplasia of overlying podocytes filling the urinary space; Global sclerosis: global solidification of tuft; Segmental collapse: segmental wrinkling and folding of the glomerular basement membranes with hypertrophy and hyperplasia of overlying podocytes; Segmental sclerosis: segmental solidification of the glomerular tuft with adhesion to the Bowman's capsule; Tubular microcysts: defined as dilated tubules containing hyaline casts. The amount of microcysts is calculated on a semiquantitative scale from 0 to 3+ (0=no cysts; ±=o10 cysts total at Â 40; 1+=1-3 cysts in at least 5 fields at Â 40; 2+=4-10 cysts in at least 5 fields at Â 40; 3+=411 cysts in at least 5 fields at Â 40). exhibited increased apoptosis compared with wild-type animals and the increase in apoptosis increased with time as CG became more advanced (Figure 5b ).
Conditional inducible deletion of Drosha in podocytes at 2 months of age also results in a CG
In order to determine whether miRNAs are required for the normal function of mature podocytes, a Tet-On system was utilized to specifically delete Drosha in podocytes in 2-month-old animals. Drosha fl/fl ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ mice were either administered or not administered doxycycline at 2 months of age and kidneys were analyzed 1 month later. Previous studies have demonstrated specific deletion of the gene of interest in 80% of podocytes in these mice using a Z/EG reporter. 36 We have also confirmed specific deletion of exon 9 of the Drosha gene in glomeruli isolated only from mice given doxycycline ( Figure 6a ). As expected, kidneys sections were normal in animals not exposed to doxycycline (Figure 6c , A and C), and these mice did not develop proteinuria (Figure 6b ). In contrast, Drosha fl/fl ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ mice administered doxycycline developed proteinuria beginning B2 weeks after starting doxycycline (Figure 6b ), which on histological examination revealed a phenotype that was very similar to the phenotype observed in the conditional KOs shown in Figure 2 . Kidneys from mice administered doxycycline for 1 month had numerous tubular microcysts accompanied by a dense interstitial inflammation (Figure 6b, B) , which on higher magnification revealed shrunken glomeruli, with collapsed capillary walls and proliferation of epithelial cells that filled the urinary space (Figure 6b, D) . Thus, these results demonstrate that miRNAs are required for the maintenance of normal podocyte function and suggest that primary changes in specific miRNAs may contribute to disease.
In order to begin to identify candidate miRNAs that are critical for normal podocyte function, glomeruli were isolated by laser capture microscopy from Drosha fl/fl ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ and Drosha fl/ þ ; podocinrtTA Tg/ þ ; tetO-Cre Tg/ þ 4 weeks following administration of doxycycline, and miRNA expression was quantitated by Taqman low density micro arrays (Applied Biosystems by Life Technologies, Carlsbad, CA). These experiments identified 10 miRNAs that were consistently undetectable in mice in which Drosha was conditionally inducibly deleted in podocytes when compared with heterozygote animals (Figure 7 ).
DISCUSSION
In this study we demonstrate that conditional deletion of Drosha in podocytes results in CG that is similar to three previous reports that studied mice with a conditional deletion of Dicer in podocytes. [24] [25] [26] Although both Drosha and Dicer have been shown to function in series to generate a mature miRNA, both RNAase molecules have distinct functions. For example, it is now appreciated that Dicer also plays a role in processing pseudogene-derived doublestranded RNAs into small inhibitory RNAs in mammals. 27, 28, 37 Thus, it remained a possibility that the kidney phenotype in podocyte-specific Dicer KOs was contributed by other functions of Dicer. Moreover, whether Dicer and by extension miRNAs are critical for function of fully differentiated mature podocytes was not addressed in these previous studies. Our findings reported here when taken together reinforce the importance for miRNAs in podocyte homeostasis and/or development, and demonstrate for the first time that mature podocytes require the continued expression of miRNAs for normal function.
Conditional deletion of Drosha in podocytes resulted in a kidney lesion with many of the hallmarks of CG. 38, 39 The earliest phenotype observed was foot process effacement on electron microscopy, which was accompanied by proteinuria. As the disease progressed, podocytes underwent dedifferentiation, leading to the loss of expression of podocytespecific genes such as podocin, nephrin, synaptopodin, and WT-1. These changes were accompanied by glomerular tuft collapse, wrinkling of the basement membrane, and pseudocrescent formation, which ultimately led to renal failure and death in most mice by 6 weeks of age.
One of the hallmarks of CG is the accumulation of proliferating epithelial cells in Bowman's space. [38] [39] [40] [41] This is in contrast to other podocyte diseases, such as focal segmental glomerular sclerosis, which is associated with podocyte loss and lack the proliferative component seen in CG. Consistent with the histological features of CG, NPHS2-Cre; Drosha fl/fl mice also had marked epithelial cell proliferation in glomeruli as assessed by Ki-67 staining. One of the controversies has been whether the proliferating cells in CG derive from dedifferentiated podocytes or the parietal epithelial cells that line the urinary space. [42] [43] [44] [45] [46] Lineagetracing experiments have provided support for the contribution of both cell types to the proliferating epithelial cells in Bowman's space, depending upon the model studied. 42, 43, 46, 47 Our finding that B80% of the proliferating epithelial cells in NPHS2-Cre; Drosha fl/fl mice express the podocyte-specific marker nestin as well as desmin suggests that the majority of cells in the urinary space that form pseudocrescents are podocytes in origin. This would be in agreement with the podocyte lineage-tracing experiments by Moeller et al. 45, 47 as well as studies by Thorner et al. 35 While the mechanism whereby podocyte injury predisposes to the formation of pseudocrescents derived predominantly from podocytes or parietal epithelial cells is still unknown, these findings raise the possibility that specific miRNAs in podocytes are critical to maintaining podocytes in a nonproliferative differentiated state. Thus, loss of specific miRNAs in some diseases that affect podocytes may be one of the factors that determine whether podocytes are able to undergo a phenotypic switch that allows them to contribute to pseudocrescent formation. This is consistent with the known functions of miRNAs in other cell types. For example, it has been shown that miR-1 and miR-206 play critical roles in skeletal muscle differentiation by maintaining skeletal muscle in a quiescent state. 48, 49 Epithelial cells derived from NPHS2-Cre; Drosha fl/fl mice express the intermediate filament desmin and a-SMA. Although desmin has been shown to be upregulated in damaged podocytes, 33, 34 our finding that desmin-positive cells in NPHS2-Cre; Drosha fl/fl mice also express SMA raises the possibility that these cells are undergoing a type 2 epithelial-mesenchymal transition (EMT), 50 ,51 which contributes to glomerular fibrosis and renal failure. EMT is not an easy diagnosis to make in vivo, as currently there is not a single specific change that marks this transition. Rather, it has now been proposed that analyzing changes in expression of a number of different markers, including cytoskelatal proteins, transcription factors, matrix proteins, cell surface receptors, and miRNAs, are required to identify cells undergoing EMT. 50 So far, we have been unable to demonstrate expression of some other markers of EMT in these cells, such as snail and b-catenin. Nevertheless, the finding that previous studies have shown that podocytes may undergo EMT in vitro, 52 together with the finding that miRNAs regulate EMT in other cells, 53 suggests that future studies should address whether podocytes undergo EMT in vivo and, if so, whether miRNAs play a role in this process.
One of the new findings reported here is that inducible conditional deletion of Drosha in podocytes at 2 months of age led to a rapid CG with proteinuria detected after o2 weeks after being treated with doxycycline. This finding not only supports the critical role for miRNAs in the maintenance of normal function of the mature podocyte, but also strongly supports the idea that primary changes in specific miRNAs in the various podocytopathies may directly mediate disease. Identifying these miRNAs and the genes they regulate will likely provide new insight into disease pathogenesis as well as novel therapeutic targets.
MATERIALS AND METHODS Mice
Podocyte-specific Drosha KOs were generated by crossing NPHS2-Cre transgenic mice with mice containing a conditional allele of Drosha fl . Drosha fl contains two loxP sites that flank exon 9.
29
NPHS2-Cre has been shown to be activated specifically in podocytes using a Rosa26 reporter. 54 Mice were genotyped by PCR using tail DNA and primer pairs as previously reported. 29, 54 Podocyte-specific Dicer KOs were generated using a similar strategy by crossing NPHS2-Cre transgenic mice with mice containing a conditional allele of Dicer fl . Dicer fl mice have been previously reported and were a generous gift of M McManus (University of California, San Francisco). 30 Both Drosha and Dicer mice were backcrossed onto a C57BL/6 genetic background for eight generations.
Histology
Mice were perfused with 4% paraformaldehyde through the heart. Kidneys were then either embedded in OCT and snap frozen or fixed in 4% paraformaldehyde overnight followed by embedding in paraffin. Periodic acid-Schiff staining was performed on 4 mm paraffin sections according to a standard protocol. 55 Immunohistochemistry Paraffin sections were immunostained using the antibodies described below and detected using the avidin-biotin immunoperoxidase technique (Vector Laboratories, Burlingame, CA) or fluorescent antibodies as previously described. 41 
Antibodies
The antibodies used in these studies were: anti-SMA (clone 1A4; Sigma, St Louis, MO), anti-synaptopodin (clone G1D4; Progen Biotechnik, Heidelberg, Germany), anti-WT-1 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-desmin (clone D33; Dako, Carpenteria, CA), anti-nestin (clone 2Q178; Santa Cruz Biotechnology, Santa Cruz, CA), anti-ZO1, Alexa Fluor 594 goat anti-rabbit IgG, and Alexa Fluor 488 goat anti-mouse immunoglobulin (Invitrogen, Carlsbad, CA). Anti-podocin anti-nephrin antibodies are rabbit polyclonal antibodies that have been previously described.
Electron microscopy
Kidney cortex was sliced into 1 mm 3 cubes, fixed in 2% glutaraldehyde solution, and then processed using a standard protocol.
Proteinuria and blood urea nitrogen determination Urine was collected and protein concentration was determined using the Bradford protein assay (Bio-Rad, Hercules, CA), 56 as well as by the separation of unconcentrated urine by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by staining with Coomassie. Blood urea nitrogen concentration on serum was determined using the QuantichromTM urea assay kit (BioAssay Systems, Hayward, CA).
Podocyte proliferation
Paraffin sections (4 mm) were stained with an antibody to Ki-67 (Dako). The PI was determined by counting the number of glomeruli with Ki-67-positive cells in the urinary space per total number of glomeruli as described in Table 4 .
Apoptosis TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining was performed with the DeadEnd Fluorometric TUNEL System as per the manufacturer's directions (Promega, Madison, WI). The number of TUNEL-positive cells per 100 glomeruli was counted in sections from three control and three mutant kidneys from each group.
Generation of conditional inducible deletion of Drosha in podocytes Drosha fl/fl mice described above were crossed to transgenic mice expressing both the reverse tetracycline transactivator (rtTA) under the control of the podocyte-specific podocin promoter NPHS2 (podocin-rrTA) and the cre recombinase driven by a minimal cytomegalovirus promoter downstream of tet operon sequences. Cre was then induced in 8-week-old mice (Drosha fl/fl ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ ) by supplementing doxycyline (4 mg/ml) to the drinking water for 1 to 2 weeks as previously described. 36 Animals were killed 4 weeks after the administration of doxycycline and kidneys were analyzed as described above. ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ mice that were either administered or not administered doxycycline and deletion of exon 9 was assessed by PCR using primers that flank the loxP site. Deletion of exon 9 results in a product of 334 base pairs, in contrast to the 2.5 Kb product in the wild-type gene. As molecular weight marker (MWM), 1 kB plus Invitrogen was used. (b) Urine (10 ml) from Drosha fl/fl ; podocin-rtTA Tg/ þ ; tetO-Cre Tg/ þ mice that were administered or not administered doxycycline for 2-4 weeks were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoreses (10%) followed by Coomassie staining. Bovine serum albumin (BSA) was run as a control. incubated with 50 ml extraction buffer and total RNA was extracted as per the manufacturer's instructions (PicoPure RNA Isolation Ki, KIT0204; Arcturus). To eliminate potential genomic DNA contamination, RNA samples were treated with RNAse-free DNase. RNA concentration was measured by nanodrop and quality assessed by bioanalyzer.
Quantitative-real time PCR profiling on TLDA arrays. Rodent TaqMan Low Density Array (TLDA) plate A and B version 2 microfluidics cards (Applied Biosystems) were used to assess the miRNA profiles. The contents of the TLDA A card comprised a total of 343 miRNAs. Experimental samples from three independent mice were profiled by ABI Prism 7900HT Sequence Detection System and miRNA levels were normalized to the average of U6 and U87 controls contained on the plate. The array data were analyzed by SDS software (Applied Biosystems) using the RQ ¼ 2.0ÀDDCT method, visualized in Agilent Genespring GX11 software (Santa Clara, CA) where they were filtered on flag calls, and then analyzed for reproducibly modulated profiles.
Verification of Drosha deletion in podocytes
Glomeruli were isolated from 2-month-old NPHS2-Cre; Drosha fl/fl mice that were either untreated or treated with doxycyline for 2 weeks. Glomeruli were then isolated using Dynabeads as previously described, 57 yielding a population of 490% glomeruli. PCR was then performed on glomerular DNA using primers flanking the loxP sites (Drosha-F 5 0 -GCAGAAAGTCTCCCACTCCT-3 0 , Drosha-R-KO 5 0 -AACAACTGGGGCTGAAGAGA-3 0 ), which detect deletion of exon 9 in the Drosha gene.
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